Cell Death and Disease · 2023 · 41 citations · 32 references
MedicineMolecular BiologyOncologyEpigeneticsMolecular OncologyNeoplasiaCancer MetabolismChromatinColorectal CancerMetabolic ReprogrammingMetabolic Reprogramming In CancerProtein DegradationChromatin RemodelingCyp24a1 DeficiencyLipid Peroxidation ResistanceNucleosome EvictionProtein RemodelingTranscriptional DerepressionUbiquitin SystemUbiquitin-mediated Proteolysis
Abstract Ferroptosis is an iron-dependent form of regulated cell death characterized by lipid peroxidation. Colorectal cancer (CRC) cells evade ferroptosis despite their requirement of substantial iron and reactive oxygen species (ROS) to sustain active metabolism and extensive proliferation. However, the underlying mechanism is unclear. Herein, we report the role of lymphoid-specific helicase (LSH), a chromatin-remodeling protein, in suppressing erastin-induced ferroptosis in CRC cells. We demonstrate that erastin treatment leads to dose- and time-dependent downregulation of LSH in CRC cells, and depletion of LSH increases cell sensitivity to ferroptosis. Mechanistically, LSH interacts with and is stabilized by ubiquitin-specific protease 11 (USP11) via deubiquitination; this interaction was disrupted by erastin treatment, resulting in increased ubiquitination and LSH degradation. Moreover, we identified cytochrome P450 family 24 subfamily A member 1 ( CYP24A1 ) as a transcriptional target of LSH. LSH binds to the CYP24A1 promoter, promoting nucleosome eviction and reducing H3K27me3 occupancy, thus leading to transcription of CYP24A1 . This cascade inhibits excessive intracellular Ca 2+ influx, thereby reducing lipid peroxidation and ultimately conferring resistance to ferroptosis. Importantly, aberrant expression of USP11, LSH, and CYP24A1 is observed in CRC tissues and correlates with poor patient prognosis. Taken together, our study demonstrates the crucial role of the USP11/LSH/CYP24A1 signaling axis in inhibiting ferroptosis in CRC, highlighting its potential as a therapeutic target in CRC treatment.
32
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang, Rohitha Sriramaratnam, Matthew Welsch et al. · Cell · 2014 · 7.5K citations · Full text
FSP1 is a glutathione-independent ferroptosis suppressor
Sebastian Doll, Florêncio Porto Freitas, Ron Shah et al. · Nature · 2019 · 3.2K citations · Full text
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang, Michael D. Green, Jae Eun Choi et al. · Nature · 2019 · 2.8K citations · Full text
Life Sciences, Immunology, Oncology +16
DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
Chao Mao, Xiaoguang Liu, Yilei Zhang et al. · Nature · 2021 · 1.8K citations · Full text